nodes	percent_of_prediction	percent_of_DWPC	metapath
Memantine—CYP2A6—Tretinoin—peripheral nervous system neoplasm	0.154	0.377	CbGbCtD
Memantine—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.1	0.245	CbGbCtD
Memantine—SLC22A2—Cisplatin—peripheral nervous system neoplasm	0.0827	0.202	CbGbCtD
Memantine—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.0429	0.105	CbGbCtD
Memantine—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.0288	0.0704	CbGbCtD
Memantine—HTR3A—vagus nerve—peripheral nervous system neoplasm	0.0104	0.121	CbGeAlD
Memantine—HTR3A—cranial nerve—peripheral nervous system neoplasm	0.00794	0.0919	CbGeAlD
Memantine—GRIN2A—Reelin signaling pathway—MAP1B—peripheral nervous system neoplasm	0.00743	0.122	CbGpPWpGaD
Memantine—GRIN1—ganglion—peripheral nervous system neoplasm	0.00727	0.0841	CbGeAlD
Memantine—GRIN2B—nerve—peripheral nervous system neoplasm	0.00703	0.0812	CbGeAlD
Memantine—GRIN2B—ganglion—peripheral nervous system neoplasm	0.00694	0.0802	CbGeAlD
Memantine—GRIN2B—Reelin signaling pathway—MAP1B—peripheral nervous system neoplasm	0.00632	0.104	CbGpPWpGaD
Memantine—GRIN2A—nerve—peripheral nervous system neoplasm	0.00614	0.071	CbGeAlD
Memantine—GRIN2A—ganglion—peripheral nervous system neoplasm	0.00606	0.0701	CbGeAlD
Memantine—HTR3A—nerve—peripheral nervous system neoplasm	0.00407	0.0471	CbGeAlD
Memantine—HTR3A—ganglion—peripheral nervous system neoplasm	0.00402	0.0465	CbGeAlD
Memantine—GRIN1—brainstem—peripheral nervous system neoplasm	0.00316	0.0366	CbGeAlD
Memantine—GRIN2B—brainstem—peripheral nervous system neoplasm	0.00302	0.0349	CbGeAlD
Memantine—GRIN2A—brainstem—peripheral nervous system neoplasm	0.00264	0.0305	CbGeAlD
Memantine—SLC22A2—Abacavir transmembrane transport—ABCB1—peripheral nervous system neoplasm	0.00252	0.0413	CbGpPWpGaD
Memantine—DRD2—nerve—peripheral nervous system neoplasm	0.00249	0.0288	CbGeAlD
Memantine—DRD2—ganglion—peripheral nervous system neoplasm	0.00246	0.0284	CbGeAlD
Memantine—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—peripheral nervous system neoplasm	0.0023	0.0377	CbGpPWpGaD
Memantine—SLC22A2—trigeminal ganglion—peripheral nervous system neoplasm	0.00229	0.0265	CbGeAlD
Memantine—HTR3A—trigeminal ganglion—peripheral nervous system neoplasm	0.00198	0.0228	CbGeAlD
Memantine—HTR3A—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.00176	0.0288	CbGpPWpGaD
Memantine—HTR3A—brainstem—peripheral nervous system neoplasm	0.00175	0.0202	CbGeAlD
Memantine—GRIN1—cerebellum—peripheral nervous system neoplasm	0.00156	0.018	CbGeAlD
Memantine—GRIN1—Mecp2 and Associated Rett Syndrome—NF1—peripheral nervous system neoplasm	0.00149	0.0245	CbGpPWpGaD
Memantine—GRIN2B—cerebellum—peripheral nervous system neoplasm	0.00149	0.0172	CbGeAlD
Memantine—GRIN1—SIDS Susceptibility Pathways—PHOX2B—peripheral nervous system neoplasm	0.00146	0.024	CbGpPWpGaD
Memantine—SLC22A2—Abacavir transport and metabolism—ABCB1—peripheral nervous system neoplasm	0.00145	0.0237	CbGpPWpGaD
Memantine—GRIN2A—cerebellum—peripheral nervous system neoplasm	0.0013	0.015	CbGeAlD
Memantine—GRIN2A—Alzheimers Disease—PPP3R1—peripheral nervous system neoplasm	0.00111	0.0182	CbGpPWpGaD
Memantine—DRD2—brainstem—peripheral nervous system neoplasm	0.00107	0.0124	CbGeAlD
Memantine—GRIN1—Alzheimers Disease—PPP3R1—peripheral nervous system neoplasm	0.000966	0.0159	CbGpPWpGaD
Memantine—GRIN2B—Alzheimers Disease—PPP3R1—peripheral nervous system neoplasm	0.000942	0.0155	CbGpPWpGaD
Memantine—DRD2—Nicotine Activity on Dopaminergic Neurons—TH—peripheral nervous system neoplasm	0.00088	0.0144	CbGpPWpGaD
Memantine—CYP2A6—cerebellum—peripheral nervous system neoplasm	0.000847	0.00979	CbGeAlD
Memantine—GRIN1—Mecp2 and Associated Rett Syndrome—BDNF—peripheral nervous system neoplasm	0.000807	0.0132	CbGpPWpGaD
Memantine—GRIN2A—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—peripheral nervous system neoplasm	0.000595	0.00976	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.000565	0.00927	CbGpPWpGaD
Memantine—GRIN2B—ErbB4 signaling events—ERBB2—peripheral nervous system neoplasm	0.000557	0.00915	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—CNTN6—peripheral nervous system neoplasm	0.000551	0.00904	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—NCAM1—peripheral nervous system neoplasm	0.000528	0.00866	CbGpPWpGaD
Memantine—DRD2—cerebellum—peripheral nervous system neoplasm	0.000527	0.0061	CbGeAlD
Memantine—CYP2A6—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000524	0.00859	CbGpPWpGaD
Memantine—GRIN1—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—peripheral nervous system neoplasm	0.000519	0.00851	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—NCAM1—peripheral nervous system neoplasm	0.000514	0.00844	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000506	0.0083	CbGpPWpGaD
Memantine—GRIN2B—Ras activation uopn Ca2+ infux through NMDA receptor—HRAS—peripheral nervous system neoplasm	0.000506	0.0083	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000463	0.00761	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—NTRK2—peripheral nervous system neoplasm	0.000449	0.00737	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—NTRK2—peripheral nervous system neoplasm	0.000437	0.00718	CbGpPWpGaD
Memantine—GRIN2A—CREB phosphorylation through the activation of Ras—HRAS—peripheral nervous system neoplasm	0.000424	0.00696	CbGpPWpGaD
Memantine—CYP2B6—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000422	0.00693	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—NTRK2—peripheral nervous system neoplasm	0.000421	0.00691	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000403	0.00662	CbGpPWpGaD
Memantine—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—peripheral nervous system neoplasm	0.000402	0.00661	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—CNTN6—peripheral nervous system neoplasm	0.000393	0.00645	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—BDNF—peripheral nervous system neoplasm	0.000393	0.00645	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—TH—peripheral nervous system neoplasm	0.000386	0.00633	CbGpPWpGaD
Memantine—GRIN2A—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000386	0.00633	CbGpPWpGaD
Memantine—GRIN2A—Reelin signaling pathway—AKT1—peripheral nervous system neoplasm	0.000385	0.00632	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000378	0.0062	CbGpPWpGaD
Memantine—GRIN1—CREB phosphorylation through the activation of Ras—HRAS—peripheral nervous system neoplasm	0.00037	0.00607	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—NTRK1—peripheral nervous system neoplasm	0.000366	0.006	CbGpPWpGaD
Memantine—GRIN2B—CREB phosphorylation through the activation of Ras—HRAS—peripheral nervous system neoplasm	0.00036	0.00592	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—NTRK1—peripheral nervous system neoplasm	0.000357	0.00585	CbGpPWpGaD
Memantine—GRIN2A—Post NMDA receptor activation events—HRAS—peripheral nervous system neoplasm	0.000349	0.00573	CbGpPWpGaD
Memantine—GRIN1—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000336	0.00552	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—BDNF—peripheral nervous system neoplasm	0.000335	0.0055	CbGpPWpGaD
Memantine—GRIN2B—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000328	0.00538	CbGpPWpGaD
Memantine—GRIN2B—Reelin signaling pathway—AKT1—peripheral nervous system neoplasm	0.000327	0.00537	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—BDNF—peripheral nervous system neoplasm	0.000327	0.00536	CbGpPWpGaD
Memantine—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—peripheral nervous system neoplasm	0.000321	0.00527	CbGpPWpGaD
Memantine—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—peripheral nervous system neoplasm	0.000319	0.00524	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—BDNF—peripheral nervous system neoplasm	0.000314	0.00516	CbGpPWpGaD
Memantine—GRIN2A—Alzheimers Disease—CASP3—peripheral nervous system neoplasm	0.00031	0.00509	CbGpPWpGaD
Memantine—GRIN1—Post NMDA receptor activation events—HRAS—peripheral nervous system neoplasm	0.000304	0.00499	CbGpPWpGaD
Memantine—HTR3A—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.0003	0.00493	CbGpPWpGaD
Memantine—GRIN2B—Post NMDA receptor activation events—HRAS—peripheral nervous system neoplasm	0.000297	0.00487	CbGpPWpGaD
Memantine—GRIN2A—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000295	0.00485	CbGpPWpGaD
Memantine—GRIN1—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—peripheral nervous system neoplasm	0.00028	0.0046	CbGpPWpGaD
Memantine—GRIN1—EPHB-mediated forward signaling—HRAS—peripheral nervous system neoplasm	0.00028	0.0046	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000276	0.00453	CbGpPWpGaD
Memantine—GRIN2B—EPHB-mediated forward signaling—HRAS—peripheral nervous system neoplasm	0.000273	0.00449	CbGpPWpGaD
Memantine—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—HRAS—peripheral nervous system neoplasm	0.000273	0.00449	CbGpPWpGaD
Memantine—GRIN1—Alzheimers Disease—CASP3—peripheral nervous system neoplasm	0.000271	0.00444	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—NCAM1—peripheral nervous system neoplasm	0.000269	0.00441	CbGpPWpGaD
Memantine—GRIN2B—Alzheimers Disease—CASP3—peripheral nervous system neoplasm	0.000264	0.00433	CbGpPWpGaD
Memantine—GRIN1—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000258	0.00423	CbGpPWpGaD
Memantine—GRIN2B—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000251	0.00412	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—PTPN11—peripheral nervous system neoplasm	0.000233	0.00383	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—PTPN11—peripheral nervous system neoplasm	0.000227	0.00373	CbGpPWpGaD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—NTS—peripheral nervous system neoplasm	0.000211	0.00346	CbGpPWpGaD
Memantine—GRIN2A—Alzheimers Disease—TP53—peripheral nervous system neoplasm	0.000199	0.00326	CbGpPWpGaD
Memantine—CYP2A6—NRF2 pathway—SLC2A1—peripheral nervous system neoplasm	0.000197	0.00323	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000197	0.00323	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—CASP3—peripheral nervous system neoplasm	0.000196	0.00322	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—NCAM1—peripheral nervous system neoplasm	0.000192	0.00315	CbGpPWpGaD
Memantine—HTR3A—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000189	0.0031	CbGpPWpGaD
Memantine—SLC22A2—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000175	0.00287	CbGpPWpGaD
Memantine—GRIN1—Alzheimers Disease—TP53—peripheral nervous system neoplasm	0.000173	0.00285	CbGpPWpGaD
Memantine—GRIN2B—Alzheimers Disease—TP53—peripheral nervous system neoplasm	0.000169	0.00278	CbGpPWpGaD
Memantine—GRIN1—BDNF signaling pathway—CASP3—peripheral nervous system neoplasm	0.000167	0.00275	CbGpPWpGaD
Memantine—CYP2A6—Fluoropyrimidine Activity—TP53—peripheral nervous system neoplasm	0.000166	0.00273	CbGpPWpGaD
Memantine—GRIN2B—BDNF signaling pathway—CASP3—peripheral nervous system neoplasm	0.000163	0.00268	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—NTS—peripheral nervous system neoplasm	0.00016	0.00263	CbGpPWpGaD
Memantine—HTR3A—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000159	0.00261	CbGpPWpGaD
Memantine—GRIN1—SIDS Susceptibility Pathways—CASP3—peripheral nervous system neoplasm	0.000157	0.00258	CbGpPWpGaD
Memantine—DRD2—GPCR ligand binding—CD55—peripheral nervous system neoplasm	0.000154	0.00252	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—MYC—peripheral nervous system neoplasm	0.000153	0.00251	CbGpPWpGaD
Memantine—CYP2A6—NRF2 pathway—HGF—peripheral nervous system neoplasm	0.000151	0.00248	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—TH—peripheral nervous system neoplasm	0.000144	0.00237	CbGpPWpGaD
Memantine—GRIN1—EPH-Ephrin signaling—HRAS—peripheral nervous system neoplasm	0.000144	0.00237	CbGpPWpGaD
Memantine—GRIN2B—EPH-Ephrin signaling—HRAS—peripheral nervous system neoplasm	0.000141	0.00231	CbGpPWpGaD
Memantine—SLC22A2—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000135	0.00222	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000135	0.00221	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000134	0.0022	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—MET—peripheral nervous system neoplasm	0.000132	0.00216	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.00013	0.00213	CbGpPWpGaD
Memantine—DRD2—Circadian rythm related genes—NTRK1—peripheral nervous system neoplasm	0.000129	0.00211	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—MET—peripheral nervous system neoplasm	0.000129	0.00211	CbGpPWpGaD
Memantine—HTR3A—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000128	0.0021	CbGpPWpGaD
Memantine—GRIN1—Spinal Cord Injury—TP53—peripheral nervous system neoplasm	0.000126	0.00207	CbGpPWpGaD
Memantine—HTR3A—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000125	0.00206	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000124	0.00203	CbGpPWpGaD
Memantine—GRIN1—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000122	0.002	CbGpPWpGaD
Memantine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	0.00012	0.00197	CbGpPWpGaD
Memantine—DRD2—G alpha (i) signalling events—KNG1—peripheral nervous system neoplasm	0.000119	0.00195	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—PTPN11—peripheral nervous system neoplasm	0.000119	0.00195	CbGpPWpGaD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	0.000115	0.00188	CbGpPWpGaD
Memantine—GRIN1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	0.000105	0.00172	CbGpPWpGaD
Memantine—DRD2—G alpha (i) signalling events—GNAS—peripheral nervous system neoplasm	0.000104	0.00171	CbGpPWpGaD
Memantine—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000232	CcSEcCtD
Memantine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000103	0.000232	CcSEcCtD
Memantine—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000231	CcSEcCtD
Memantine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000103	0.000231	CcSEcCtD
Memantine—GRIN1—BDNF signaling pathway—HRAS—peripheral nervous system neoplasm	0.000103	0.00168	CbGpPWpGaD
Memantine—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—peripheral nervous system neoplasm	0.000102	0.00168	CbGpPWpGaD
Memantine—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000102	0.00023	CcSEcCtD
Memantine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000102	0.00023	CcSEcCtD
Memantine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000102	0.000229	CcSEcCtD
Memantine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000229	CcSEcCtD
Memantine—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000228	CcSEcCtD
Memantine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000101	0.000228	CcSEcCtD
Memantine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000101	0.000228	CcSEcCtD
Memantine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000101	0.000228	CcSEcCtD
Memantine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000227	CcSEcCtD
Memantine—Pain—Etoposide—peripheral nervous system neoplasm	0.0001	0.000226	CcSEcCtD
Memantine—Constipation—Etoposide—peripheral nervous system neoplasm	0.0001	0.000226	CcSEcCtD
Memantine—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000225	CcSEcCtD
Memantine—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000225	CcSEcCtD
Memantine—GRIN2B—BDNF signaling pathway—HRAS—peripheral nervous system neoplasm	0.0001	0.00164	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—PPIP5K2—peripheral nervous system neoplasm	9.99e-05	0.00164	CbGpPWpGaD
Memantine—Dysuria—Doxorubicin—peripheral nervous system neoplasm	9.99e-05	0.000225	CcSEcCtD
Memantine—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	9.99e-05	0.000225	CcSEcCtD
Memantine—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	9.93e-05	0.000224	CcSEcCtD
Memantine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	9.92e-05	0.000224	CcSEcCtD
Memantine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	9.89e-05	0.000223	CcSEcCtD
Memantine—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	9.87e-05	0.000222	CcSEcCtD
Memantine—Haematuria—Epirubicin—peripheral nervous system neoplasm	9.82e-05	0.000221	CcSEcCtD
Memantine—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	9.74e-05	0.000219	CcSEcCtD
Memantine—Weight increased—Doxorubicin—peripheral nervous system neoplasm	9.72e-05	0.000219	CcSEcCtD
Memantine—Epistaxis—Epirubicin—peripheral nervous system neoplasm	9.71e-05	0.000219	CcSEcCtD
Memantine—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	9.67e-05	0.000218	CcSEcCtD
Memantine—Sinusitis—Epirubicin—peripheral nervous system neoplasm	9.66e-05	0.000218	CcSEcCtD
Memantine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	9.65e-05	0.000217	CcSEcCtD
Memantine—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	9.64e-05	0.000217	CcSEcCtD
Memantine—GRIN1—Axon guidance—ERBB2—peripheral nervous system neoplasm	9.64e-05	0.00158	CbGpPWpGaD
Memantine—Nausea—Dactinomycin—peripheral nervous system neoplasm	9.61e-05	0.000217	CcSEcCtD
Memantine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	9.61e-05	0.000216	CcSEcCtD
Memantine—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	9.58e-05	0.000216	CcSEcCtD
Memantine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	9.58e-05	0.000216	CcSEcCtD
Memantine—Dizziness—Vincristine—peripheral nervous system neoplasm	9.56e-05	0.000215	CcSEcCtD
Memantine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	9.54e-05	0.000215	CcSEcCtD
Memantine—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	9.53e-05	0.000215	CcSEcCtD
Memantine—Infestation—Doxorubicin—peripheral nervous system neoplasm	9.53e-05	0.000215	CcSEcCtD
Memantine—DRD2—Class A/1 (Rhodopsin-like receptors)—KNG1—peripheral nervous system neoplasm	9.46e-05	0.00155	CbGpPWpGaD
Memantine—Rash—Alitretinoin—peripheral nervous system neoplasm	9.46e-05	0.000213	CcSEcCtD
Memantine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	9.45e-05	0.000213	CcSEcCtD
Memantine—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	9.45e-05	0.000213	CcSEcCtD
Memantine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	9.42e-05	0.000212	CcSEcCtD
Memantine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	9.41e-05	0.000212	CcSEcCtD
Memantine—GRIN1—Developmental Biology—MET—peripheral nervous system neoplasm	9.41e-05	0.00154	CbGpPWpGaD
Memantine—Headache—Alitretinoin—peripheral nervous system neoplasm	9.4e-05	0.000212	CcSEcCtD
Memantine—GRIN2B—Axon guidance—ERBB2—peripheral nervous system neoplasm	9.39e-05	0.00154	CbGpPWpGaD
Memantine—Renal failure—Doxorubicin—peripheral nervous system neoplasm	9.37e-05	0.000211	CcSEcCtD
Memantine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	9.34e-05	0.00021	CcSEcCtD
Memantine—Urticaria—Etoposide—peripheral nervous system neoplasm	9.31e-05	0.00021	CcSEcCtD
Memantine—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	9.29e-05	0.000209	CcSEcCtD
Memantine—Rhinitis—Epirubicin—peripheral nervous system neoplasm	9.27e-05	0.000209	CcSEcCtD
Memantine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	9.26e-05	0.000209	CcSEcCtD
Memantine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	9.26e-05	0.000209	CcSEcCtD
Memantine—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	9.26e-05	0.000209	CcSEcCtD
Memantine—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	9.26e-05	0.000209	CcSEcCtD
Memantine—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	9.24e-05	0.000208	CcSEcCtD
Memantine—Hepatitis—Epirubicin—peripheral nervous system neoplasm	9.24e-05	0.000208	CcSEcCtD
Memantine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	9.2e-05	0.000207	CcSEcCtD
Memantine—Vomiting—Vincristine—peripheral nervous system neoplasm	9.2e-05	0.000207	CcSEcCtD
Memantine—Asthenia—Cisplatin—peripheral nervous system neoplasm	9.17e-05	0.000207	CcSEcCtD
Memantine—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	9.17e-05	0.000207	CcSEcCtD
Memantine—GRIN2B—Developmental Biology—MET—peripheral nervous system neoplasm	9.17e-05	0.00151	CbGpPWpGaD
Memantine—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	9.13e-05	0.000206	CcSEcCtD
Memantine—Rash—Vincristine—peripheral nervous system neoplasm	9.12e-05	0.000205	CcSEcCtD
Memantine—SLC22A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	9.11e-05	0.0015	CbGpPWpGaD
Memantine—Dermatitis—Vincristine—peripheral nervous system neoplasm	9.11e-05	0.000205	CcSEcCtD
Memantine—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	9.11e-05	0.000205	CcSEcCtD
Memantine—Haematuria—Doxorubicin—peripheral nervous system neoplasm	9.08e-05	0.000205	CcSEcCtD
Memantine—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	9.08e-05	0.000205	CcSEcCtD
Memantine—DRD2—GPCR downstream signaling—NTS—peripheral nervous system neoplasm	9.06e-05	0.00149	CbGpPWpGaD
Memantine—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	9.06e-05	0.000204	CcSEcCtD
Memantine—GRIN1—BDNF signaling pathway—AKT1—peripheral nervous system neoplasm	9.06e-05	0.00149	CbGpPWpGaD
Memantine—Headache—Vincristine—peripheral nervous system neoplasm	9.06e-05	0.000204	CcSEcCtD
Memantine—GRIN2A—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	9.05e-05	0.00148	CbGpPWpGaD
Memantine—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	9.01e-05	0.000203	CcSEcCtD
Memantine—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	8.99e-05	0.000202	CcSEcCtD
Memantine—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	8.94e-05	0.000201	CcSEcCtD
Memantine—Nausea—Alitretinoin—peripheral nervous system neoplasm	8.91e-05	0.000201	CcSEcCtD
Memantine—Visual impairment—Epirubicin—peripheral nervous system neoplasm	8.91e-05	0.000201	CcSEcCtD
Memantine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	8.89e-05	0.0002	CcSEcCtD
Memantine—GRIN2B—BDNF signaling pathway—AKT1—peripheral nervous system neoplasm	8.83e-05	0.00145	CbGpPWpGaD
Memantine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	8.75e-05	0.000197	CcSEcCtD
Memantine—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	8.74e-05	0.000197	CcSEcCtD
Memantine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	8.71e-05	0.000196	CcSEcCtD
Memantine—GRIN1—Developmental Biology—PTPN11—peripheral nervous system neoplasm	8.7e-05	0.00143	CbGpPWpGaD
Memantine—Eye disorder—Epirubicin—peripheral nervous system neoplasm	8.64e-05	0.000195	CcSEcCtD
Memantine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	8.63e-05	0.000194	CcSEcCtD
Memantine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	8.62e-05	0.000194	CcSEcCtD
Memantine—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	8.6e-05	0.000194	CcSEcCtD
Memantine—Nausea—Vincristine—peripheral nervous system neoplasm	8.59e-05	0.000194	CcSEcCtD
Memantine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	8.58e-05	0.000193	CcSEcCtD
Memantine—Flushing—Epirubicin—peripheral nervous system neoplasm	8.58e-05	0.000193	CcSEcCtD
Memantine—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	8.57e-05	0.000193	CcSEcCtD
Memantine—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	8.55e-05	0.000193	CcSEcCtD
Memantine—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	8.55e-05	0.000193	CcSEcCtD
Memantine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	8.51e-05	0.000192	CcSEcCtD
Memantine—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	8.49e-05	0.000191	CcSEcCtD
Memantine—GRIN2B—Developmental Biology—PTPN11—peripheral nervous system neoplasm	8.48e-05	0.00139	CbGpPWpGaD
Memantine—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	8.45e-05	0.00019	CcSEcCtD
Memantine—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	8.43e-05	0.00019	CcSEcCtD
Memantine—Asthenia—Etoposide—peripheral nervous system neoplasm	8.41e-05	0.000189	CcSEcCtD
Memantine—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	8.4e-05	0.000189	CcSEcCtD
Memantine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	8.39e-05	0.000189	CcSEcCtD
Memantine—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	8.38e-05	0.000189	CcSEcCtD
Memantine—CYP2A6—Metabolism—HSD17B12—peripheral nervous system neoplasm	8.37e-05	0.00137	CbGpPWpGaD
Memantine—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	8.35e-05	0.000188	CcSEcCtD
Memantine—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	8.33e-05	0.000188	CcSEcCtD
Memantine—Chills—Epirubicin—peripheral nervous system neoplasm	8.29e-05	0.000187	CcSEcCtD
Memantine—Pruritus—Etoposide—peripheral nervous system neoplasm	8.29e-05	0.000187	CcSEcCtD
Memantine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	8.26e-05	0.000186	CcSEcCtD
Memantine—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	8.24e-05	0.000186	CcSEcCtD
Memantine—DRD2—Signaling by GPCR—NTS—peripheral nervous system neoplasm	8.23e-05	0.00135	CbGpPWpGaD
Memantine—Alopecia—Epirubicin—peripheral nervous system neoplasm	8.17e-05	0.000184	CcSEcCtD
Memantine—Vomiting—Cisplatin—peripheral nervous system neoplasm	8.13e-05	0.000183	CcSEcCtD
Memantine—Mental disorder—Epirubicin—peripheral nervous system neoplasm	8.1e-05	0.000182	CcSEcCtD
Memantine—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	8.09e-05	0.000182	CcSEcCtD
Memantine—Rash—Cisplatin—peripheral nervous system neoplasm	8.06e-05	0.000182	CcSEcCtD
Memantine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	8.06e-05	0.000181	CcSEcCtD
Memantine—Malnutrition—Epirubicin—peripheral nervous system neoplasm	8.05e-05	0.000181	CcSEcCtD
Memantine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	8.02e-05	0.000181	CcSEcCtD
Memantine—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	7.99e-05	0.00018	CcSEcCtD
Memantine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	7.97e-05	0.00018	CcSEcCtD
Memantine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	7.94e-05	0.000179	CcSEcCtD
Memantine—Flushing—Doxorubicin—peripheral nervous system neoplasm	7.94e-05	0.000179	CcSEcCtD
Memantine—Flatulence—Epirubicin—peripheral nervous system neoplasm	7.93e-05	0.000179	CcSEcCtD
Memantine—Tension—Epirubicin—peripheral nervous system neoplasm	7.9e-05	0.000178	CcSEcCtD
Memantine—DRD2—Signaling by GPCR—CD55—peripheral nervous system neoplasm	7.89e-05	0.0013	CbGpPWpGaD
Memantine—GRIN1—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	7.89e-05	0.00129	CbGpPWpGaD
Memantine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	7.88e-05	0.000178	CcSEcCtD
Memantine—Nervousness—Epirubicin—peripheral nervous system neoplasm	7.81e-05	0.000176	CcSEcCtD
Memantine—Back pain—Epirubicin—peripheral nervous system neoplasm	7.78e-05	0.000175	CcSEcCtD
Memantine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	7.76e-05	0.000175	CcSEcCtD
Memantine—Dizziness—Etoposide—peripheral nervous system neoplasm	7.75e-05	0.000175	CcSEcCtD
Memantine—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	7.73e-05	0.000174	CcSEcCtD
Memantine—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	7.71e-05	0.000174	CcSEcCtD
Memantine—GRIN2B—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	7.69e-05	0.00126	CbGpPWpGaD
Memantine—Chills—Doxorubicin—peripheral nervous system neoplasm	7.67e-05	0.000173	CcSEcCtD
Memantine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	7.64e-05	0.000172	CcSEcCtD
Memantine—Nausea—Cisplatin—peripheral nervous system neoplasm	7.6e-05	0.000171	CcSEcCtD
Memantine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	7.58e-05	0.000171	CcSEcCtD
Memantine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	7.56e-05	0.00017	CcSEcCtD
Memantine—CYP2C19—Metabolism—PPIP5K2—peripheral nervous system neoplasm	7.55e-05	0.00124	CbGpPWpGaD
Memantine—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	7.49e-05	0.000169	CcSEcCtD
Memantine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	7.47e-05	0.000168	CcSEcCtD
Memantine—Vomiting—Etoposide—peripheral nervous system neoplasm	7.45e-05	0.000168	CcSEcCtD
Memantine—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	7.45e-05	0.000168	CcSEcCtD
Memantine—Anaemia—Epirubicin—peripheral nervous system neoplasm	7.44e-05	0.000168	CcSEcCtD
Memantine—Agitation—Epirubicin—peripheral nervous system neoplasm	7.39e-05	0.000167	CcSEcCtD
Memantine—Rash—Etoposide—peripheral nervous system neoplasm	7.39e-05	0.000166	CcSEcCtD
Memantine—Dermatitis—Etoposide—peripheral nervous system neoplasm	7.38e-05	0.000166	CcSEcCtD
Memantine—Headache—Etoposide—peripheral nervous system neoplasm	7.34e-05	0.000165	CcSEcCtD
Memantine—Flatulence—Doxorubicin—peripheral nervous system neoplasm	7.34e-05	0.000165	CcSEcCtD
Memantine—GRIN1—Axon guidance—NRAS—peripheral nervous system neoplasm	7.33e-05	0.0012	CbGpPWpGaD
Memantine—Tension—Doxorubicin—peripheral nervous system neoplasm	7.31e-05	0.000165	CcSEcCtD
Memantine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	7.29e-05	0.000164	CcSEcCtD
Memantine—Malaise—Epirubicin—peripheral nervous system neoplasm	7.26e-05	0.000163	CcSEcCtD
Memantine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	7.23e-05	0.000163	CcSEcCtD
Memantine—Vertigo—Epirubicin—peripheral nervous system neoplasm	7.23e-05	0.000163	CcSEcCtD
Memantine—Syncope—Epirubicin—peripheral nervous system neoplasm	7.22e-05	0.000163	CcSEcCtD
Memantine—DRD2—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	7.21e-05	0.00118	CbGpPWpGaD
Memantine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	7.2e-05	0.000162	CcSEcCtD
Memantine—Back pain—Doxorubicin—peripheral nervous system neoplasm	7.2e-05	0.000162	CcSEcCtD
Memantine—GRIN2B—Axon guidance—NRAS—peripheral nervous system neoplasm	7.15e-05	0.00117	CbGpPWpGaD
Memantine—Palpitations—Epirubicin—peripheral nervous system neoplasm	7.11e-05	0.00016	CcSEcCtD
Memantine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	7.07e-05	0.000159	CcSEcCtD
Memantine—Cough—Epirubicin—peripheral nervous system neoplasm	7.02e-05	0.000158	CcSEcCtD
Memantine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	7.02e-05	0.000158	CcSEcCtD
Memantine—Convulsion—Epirubicin—peripheral nervous system neoplasm	6.97e-05	0.000157	CcSEcCtD
Memantine—Nausea—Etoposide—peripheral nervous system neoplasm	6.96e-05	0.000157	CcSEcCtD
Memantine—Hypertension—Epirubicin—peripheral nervous system neoplasm	6.95e-05	0.000156	CcSEcCtD
Memantine—GRIN2A—Neuronal System—HRAS—peripheral nervous system neoplasm	6.93e-05	0.00114	CbGpPWpGaD
Memantine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	6.91e-05	0.000156	CcSEcCtD
Memantine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	6.88e-05	0.000155	CcSEcCtD
Memantine—GRIN1—Developmental Biology—ERBB2—peripheral nervous system neoplasm	6.88e-05	0.00113	CbGpPWpGaD
Memantine—SLC22A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	6.87e-05	0.00113	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	6.87e-05	0.00113	CbGpPWpGaD
Memantine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	6.85e-05	0.000154	CcSEcCtD
Memantine—Chest pain—Epirubicin—peripheral nervous system neoplasm	6.85e-05	0.000154	CcSEcCtD
Memantine—Myalgia—Epirubicin—peripheral nervous system neoplasm	6.85e-05	0.000154	CcSEcCtD
Memantine—Agitation—Doxorubicin—peripheral nervous system neoplasm	6.84e-05	0.000154	CcSEcCtD
Memantine—Anxiety—Epirubicin—peripheral nervous system neoplasm	6.83e-05	0.000154	CcSEcCtD
Memantine—Discomfort—Epirubicin—peripheral nervous system neoplasm	6.77e-05	0.000152	CcSEcCtD
Memantine—CYP2B6—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.75e-05	0.00111	CbGpPWpGaD
Memantine—Malaise—Doxorubicin—peripheral nervous system neoplasm	6.71e-05	0.000151	CcSEcCtD
Memantine—GRIN2B—Developmental Biology—ERBB2—peripheral nervous system neoplasm	6.7e-05	0.0011	CbGpPWpGaD
Memantine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	6.7e-05	0.000151	CcSEcCtD
Memantine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	6.69e-05	0.000151	CcSEcCtD
Memantine—Syncope—Doxorubicin—peripheral nervous system neoplasm	6.68e-05	0.00015	CcSEcCtD
Memantine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	6.66e-05	0.00015	CcSEcCtD
Memantine—Confusional state—Epirubicin—peripheral nervous system neoplasm	6.62e-05	0.000149	CcSEcCtD
Memantine—SLC22A2—Metabolism—GNS—peripheral nervous system neoplasm	6.59e-05	0.00108	CbGpPWpGaD
Memantine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	6.58e-05	0.000148	CcSEcCtD
Memantine—Oedema—Epirubicin—peripheral nervous system neoplasm	6.57e-05	0.000148	CcSEcCtD
Memantine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	6.54e-05	0.000147	CcSEcCtD
Memantine—Infection—Epirubicin—peripheral nervous system neoplasm	6.52e-05	0.000147	CcSEcCtD
Memantine—Cough—Doxorubicin—peripheral nervous system neoplasm	6.5e-05	0.000146	CcSEcCtD
Memantine—Shock—Epirubicin—peripheral nervous system neoplasm	6.46e-05	0.000146	CcSEcCtD
Memantine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	6.45e-05	0.000145	CcSEcCtD
Memantine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	6.44e-05	0.000145	CcSEcCtD
Memantine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	6.43e-05	0.000145	CcSEcCtD
Memantine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	6.43e-05	0.000145	CcSEcCtD
Memantine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	6.41e-05	0.000144	CcSEcCtD
Memantine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	6.38e-05	0.000144	CcSEcCtD
Memantine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	6.35e-05	0.000143	CcSEcCtD
Memantine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	6.34e-05	0.000143	CcSEcCtD
Memantine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	6.34e-05	0.000143	CcSEcCtD
Memantine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	6.34e-05	0.000143	CcSEcCtD
Memantine—SLC22A2—Metabolism—NME1—peripheral nervous system neoplasm	6.32e-05	0.00104	CbGpPWpGaD
Memantine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	6.32e-05	0.000142	CcSEcCtD
Memantine—DRD2—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	6.3e-05	0.00103	CbGpPWpGaD
Memantine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	6.26e-05	0.000141	CcSEcCtD
Memantine—Anorexia—Epirubicin—peripheral nervous system neoplasm	6.26e-05	0.000141	CcSEcCtD
Memantine—DRD2—Signaling by GPCR—VIP—peripheral nervous system neoplasm	6.24e-05	0.00102	CbGpPWpGaD
Memantine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	6.2e-05	0.00014	CcSEcCtD
Memantine—Hypotension—Epirubicin—peripheral nervous system neoplasm	6.14e-05	0.000138	CcSEcCtD
Memantine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	6.13e-05	0.000138	CcSEcCtD
Memantine—SLC22A2—Metabolism—COX2—peripheral nervous system neoplasm	6.08e-05	0.000998	CbGpPWpGaD
Memantine—Oedema—Doxorubicin—peripheral nervous system neoplasm	6.08e-05	0.000137	CcSEcCtD
Memantine—CYP2A6—Metabolism—GNS—peripheral nervous system neoplasm	6.05e-05	0.000993	CbGpPWpGaD
Memantine—GRIN1—Neuronal System—HRAS—peripheral nervous system neoplasm	6.04e-05	0.000992	CbGpPWpGaD
Memantine—Infection—Doxorubicin—peripheral nervous system neoplasm	6.04e-05	0.000136	CcSEcCtD
Memantine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	5.98e-05	0.000135	CcSEcCtD
Memantine—Shock—Doxorubicin—peripheral nervous system neoplasm	5.98e-05	0.000135	CcSEcCtD
Memantine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	5.96e-05	0.000134	CcSEcCtD
Memantine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	5.95e-05	0.000134	CcSEcCtD
Memantine—Insomnia—Epirubicin—peripheral nervous system neoplasm	5.94e-05	0.000134	CcSEcCtD
Memantine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	5.93e-05	0.000134	CcSEcCtD
Memantine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	5.9e-05	0.000133	CcSEcCtD
Memantine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	5.9e-05	0.000133	CcSEcCtD
Memantine—GRIN2B—Neuronal System—HRAS—peripheral nervous system neoplasm	5.89e-05	0.000967	CbGpPWpGaD
Memantine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	5.87e-05	0.000132	CcSEcCtD
Memantine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	5.85e-05	0.000132	CcSEcCtD
Memantine—Somnolence—Epirubicin—peripheral nervous system neoplasm	5.84e-05	0.000132	CcSEcCtD
Memantine—CYP2A6—Metabolism—NME1—peripheral nervous system neoplasm	5.8e-05	0.000952	CbGpPWpGaD
Memantine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	5.79e-05	0.00013	CcSEcCtD
Memantine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	5.78e-05	0.00013	CcSEcCtD
Memantine—DRD2—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	5.76e-05	0.000945	CbGpPWpGaD
Memantine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	5.71e-05	0.000129	CcSEcCtD
Memantine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	5.68e-05	0.000128	CcSEcCtD
Memantine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	5.67e-05	0.000128	CcSEcCtD
Memantine—Fatigue—Epirubicin—peripheral nervous system neoplasm	5.66e-05	0.000128	CcSEcCtD
Memantine—Pain—Epirubicin—peripheral nervous system neoplasm	5.62e-05	0.000127	CcSEcCtD
Memantine—Constipation—Epirubicin—peripheral nervous system neoplasm	5.62e-05	0.000127	CcSEcCtD
Memantine—CYP2A6—Metabolism—COX2—peripheral nervous system neoplasm	5.58e-05	0.000916	CbGpPWpGaD
Memantine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	5.54e-05	0.000125	CcSEcCtD
Memantine—SLC22A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	5.53e-05	0.000907	CbGpPWpGaD
Memantine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	5.5e-05	0.000124	CcSEcCtD
Memantine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	5.46e-05	0.000123	CcSEcCtD
Memantine—SLC22A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	5.42e-05	0.00089	CbGpPWpGaD
Memantine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	5.42e-05	0.000122	CcSEcCtD
Memantine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	5.41e-05	0.000122	CcSEcCtD
Memantine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	5.4e-05	0.000122	CcSEcCtD
Memantine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	5.37e-05	0.000121	CcSEcCtD
Memantine—GRIN1—Axon guidance—HRAS—peripheral nervous system neoplasm	5.36e-05	0.00088	CbGpPWpGaD
Memantine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	5.35e-05	0.00012	CcSEcCtD
Memantine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	5.28e-05	0.000119	CcSEcCtD
Memantine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	5.25e-05	0.000118	CcSEcCtD
Memantine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	5.24e-05	0.000118	CcSEcCtD
Memantine—GRIN1—Developmental Biology—NRAS—peripheral nervous system neoplasm	5.23e-05	0.000859	CbGpPWpGaD
Memantine—GRIN2B—Axon guidance—HRAS—peripheral nervous system neoplasm	5.23e-05	0.000858	CbGpPWpGaD
Memantine—Urticaria—Epirubicin—peripheral nervous system neoplasm	5.22e-05	0.000118	CcSEcCtD
Memantine—Pain—Doxorubicin—peripheral nervous system neoplasm	5.2e-05	0.000117	CcSEcCtD
Memantine—Constipation—Doxorubicin—peripheral nervous system neoplasm	5.2e-05	0.000117	CcSEcCtD
Memantine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	5.19e-05	0.000117	CcSEcCtD
Memantine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	5.19e-05	0.000117	CcSEcCtD
Memantine—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.1e-05	0.000837	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—NRAS—peripheral nervous system neoplasm	5.1e-05	0.000837	CbGpPWpGaD
Memantine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	5.01e-05	0.000113	CcSEcCtD
Memantine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	4.97e-05	0.000112	CcSEcCtD
Memantine—CYP2B6—Metabolism—GNS—peripheral nervous system neoplasm	4.88e-05	0.000801	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NTS—peripheral nervous system neoplasm	4.86e-05	0.000798	CbGpPWpGaD
Memantine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	4.84e-05	0.000109	CcSEcCtD
Memantine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	4.83e-05	0.000109	CcSEcCtD
Memantine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	4.8e-05	0.000108	CcSEcCtD
Memantine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	4.8e-05	0.000108	CcSEcCtD
Memantine—Asthenia—Epirubicin—peripheral nervous system neoplasm	4.71e-05	0.000106	CcSEcCtD
Memantine—CYP2B6—Metabolism—NME1—peripheral nervous system neoplasm	4.68e-05	0.000768	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CD55—peripheral nervous system neoplasm	4.66e-05	0.000765	CbGpPWpGaD
Memantine—Pruritus—Epirubicin—peripheral nervous system neoplasm	4.65e-05	0.000105	CcSEcCtD
Memantine—CYP2B6—Metabolism—COX2—peripheral nervous system neoplasm	4.5e-05	0.000739	CbGpPWpGaD
Memantine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	4.49e-05	0.000101	CcSEcCtD
Memantine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	4.48e-05	0.000101	CcSEcCtD
Memantine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	4.36e-05	9.82e-05	CcSEcCtD
Memantine—Dizziness—Epirubicin—peripheral nervous system neoplasm	4.34e-05	9.78e-05	CcSEcCtD
Memantine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	4.3e-05	9.68e-05	CcSEcCtD
Memantine—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.24e-05	0.000696	CbGpPWpGaD
Memantine—Vomiting—Epirubicin—peripheral nervous system neoplasm	4.18e-05	9.41e-05	CcSEcCtD
Memantine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	4.16e-05	9.37e-05	CcSEcCtD
Memantine—Rash—Epirubicin—peripheral nervous system neoplasm	4.14e-05	9.33e-05	CcSEcCtD
Memantine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	4.14e-05	9.32e-05	CcSEcCtD
Memantine—Headache—Epirubicin—peripheral nervous system neoplasm	4.11e-05	9.27e-05	CcSEcCtD
Memantine—SLC22A2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	4.1e-05	0.000673	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	4.07e-05	0.000668	CbGpPWpGaD
Memantine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	4.02e-05	9.05e-05	CcSEcCtD
Memantine—SLC22A2—Metabolism—ENO2—peripheral nervous system neoplasm	3.99e-05	0.000655	CbGpPWpGaD
Memantine—Nausea—Epirubicin—peripheral nervous system neoplasm	3.9e-05	8.79e-05	CcSEcCtD
Memantine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	3.86e-05	8.7e-05	CcSEcCtD
Memantine—Rash—Doxorubicin—peripheral nervous system neoplasm	3.83e-05	8.63e-05	CcSEcCtD
Memantine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	3.83e-05	8.62e-05	CcSEcCtD
Memantine—GRIN1—Developmental Biology—HRAS—peripheral nervous system neoplasm	3.83e-05	0.000628	CbGpPWpGaD
Memantine—Headache—Doxorubicin—peripheral nervous system neoplasm	3.81e-05	8.58e-05	CcSEcCtD
Memantine—DRD2—Circadian rythm related genes—TP53—peripheral nervous system neoplasm	3.77e-05	0.000619	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—HRAS—peripheral nervous system neoplasm	3.73e-05	0.000612	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	3.7e-05	0.000607	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	3.69e-05	0.000605	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—VIP—peripheral nervous system neoplasm	3.68e-05	0.000605	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ENO2—peripheral nervous system neoplasm	3.66e-05	0.000601	CbGpPWpGaD
Memantine—Nausea—Doxorubicin—peripheral nervous system neoplasm	3.61e-05	8.13e-05	CcSEcCtD
Memantine—DRD2—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	3.56e-05	0.000585	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	3.54e-05	0.00058	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	3.4e-05	0.000559	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	3.4e-05	0.000558	CbGpPWpGaD
Memantine—GRIN1—Developmental Biology—AKT1—peripheral nervous system neoplasm	3.38e-05	0.000555	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—BCHE—peripheral nervous system neoplasm	3.37e-05	0.000554	CbGpPWpGaD
Memantine—GRIN2B—Developmental Biology—AKT1—peripheral nervous system neoplasm	3.29e-05	0.000541	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	3.23e-05	0.000531	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	3.22e-05	0.000528	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—TH—peripheral nervous system neoplasm	3.17e-05	0.00052	CbGpPWpGaD
Memantine—SLC22A2—Neuronal System—HRAS—peripheral nervous system neoplasm	3.14e-05	0.000516	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—BCHE—peripheral nervous system neoplasm	3.1e-05	0.000508	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ENO2—peripheral nervous system neoplasm	2.96e-05	0.000485	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.95e-05	0.000485	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—TH—peripheral nervous system neoplasm	2.91e-05	0.000478	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—GNAS—peripheral nervous system neoplasm	2.59e-05	0.000425	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.55e-05	0.000419	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—ABCB1—peripheral nervous system neoplasm	2.54e-05	0.000417	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—BCHE—peripheral nervous system neoplasm	2.5e-05	0.00041	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.38e-05	0.000391	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—GNAS—peripheral nervous system neoplasm	2.38e-05	0.00039	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—TH—peripheral nervous system neoplasm	2.35e-05	0.000386	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—ABCB1—peripheral nervous system neoplasm	2.33e-05	0.000383	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	2.25e-05	0.000369	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	2.23e-05	0.000367	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—KNG1—peripheral nervous system neoplasm	2.18e-05	0.000359	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	2.08e-05	0.000342	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—GNAS—peripheral nervous system neoplasm	1.92e-05	0.000315	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.91e-05	0.000314	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	1.89e-05	0.00031	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.88e-05	0.000309	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.8e-05	0.000296	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	1.77e-05	0.000291	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	1.45e-05	0.000238	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	1.42e-05	0.000233	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.35e-05	0.000222	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.33e-05	0.000218	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	1.05e-05	0.000172	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	9.89e-06	0.000162	CbGpPWpGaD
Memantine—DRD2—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	9.61e-06	0.000158	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—CASP3—peripheral nervous system neoplasm	9.52e-06	0.000156	CbGpPWpGaD
Memantine—DRD2—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	8.73e-06	0.000143	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—NRAS—peripheral nervous system neoplasm	7.98e-06	0.000131	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—MYC—peripheral nervous system neoplasm	7.44e-06	0.000122	CbGpPWpGaD
Memantine—SLC22A2—Metabolism—AKT1—peripheral nervous system neoplasm	6.99e-06	0.000115	CbGpPWpGaD
Memantine—CYP2A6—Metabolism—AKT1—peripheral nervous system neoplasm	6.41e-06	0.000105	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—TP53—peripheral nervous system neoplasm	6.11e-06	0.0001	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—HRAS—peripheral nervous system neoplasm	5.84e-06	9.59e-05	CbGpPWpGaD
Memantine—CYP2B6—Metabolism—AKT1—peripheral nervous system neoplasm	5.18e-06	8.49e-05	CbGpPWpGaD
Memantine—DRD2—Signaling Pathways—AKT1—peripheral nervous system neoplasm	5.16e-06	8.46e-05	CbGpPWpGaD
Memantine—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	3.91e-06	6.42e-05	CbGpPWpGaD
